ARTA
AMRX icon

A.R.T. Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

A.R.T. Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-104,515
Closed -$504K – 93
2019
Q4 		$504K Sell
104,515
-62,320
-37% -$217K 0.02% 853
2019
Q3 		$484K Buy
166,835
+124,700
+296% +$435K 0.02% 876
2019
Q2 		$302K Sell
42,135
-23,000
-35% -$235K 0.02% 953
2019
Q1 		$923K Buy
65,135
+45,400
+230% +$600K 0.06% 515
2018
Q4 		$267K Sell
19,735
-33,400
-63% -$602K 0.02% 970
2018
Q3 		$1.18M Buy
53,135
+15,600
+42% +$328K 0.05% 503
2018
Q2 		$615K Buy
+37,535
New +$659K 0.03% 840

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

A.R.T. Advisors's AMRX Position: Q1 2020 in Review

A.R.T. Advisors sold out of Amneal Pharmaceuticals (AMRX) in Q1 2020, closing a stake of 104,515 shares — an estimated $504K sold.

A.R.T. Advisors first reported a position in AMRX in Q2 2018 and held it in 7 quarters. The position peaked at $1.18M in Q3 2018. 127 funds tracked by Wall St. Rank hold AMRX as of Q1 2020.

  • A.R.T. Advisors reported no remaining Amneal Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 104,515 Amneal Pharmaceuticals shares in Q1 2020, an estimated $504K.
  • A.R.T. Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • A.R.T. Advisors's Amneal Pharmaceuticals position peaked at $1.18M in Q3 2018.
  • 127 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.